Yiallouros, I.; Vassiliou, S.; Yiotakis, A.; Zwilling, R.; Stocker, W.;and Dive Vincent, “Phosphinic Peptide the First Potent Inhibitors of Astacin Behave as Extremely Slow-Binding Inhibitors”, Biochen. J., 331: 375-379 (Arp. 1998). |
Bond, J. S., and Beynon, R. J., “The Astacin Family of Metalloendopeptidases”, Prot. Sci., 4(7): 1247-1261 (1995). |
Yiotakis, A.; Vassiliou, S.; Jiracek, J.; and Dive, V., “Protection of the Hydroxyphophinyl Function ofPhosphinic Dipeptides by Adamantyl. Application to the Solid-Phase Synthesis of Phosphinic Peptides”, J. Org. Chem., 61(19): 6601-6605 (1996). |
Kessler, E., Takahara, K., Biniaminov, L., Brusel, M., Greenspan, D. S., “Bone Morphogenetic Protein-1: The Type 1 Procollagen C-Proteinase”, Science, 271: 360-362 (Jan. 1996). |
Panchenko, M. V., Stetler-Stevenson, W. G., Trubetskoy, O. V., Gacheru, S. N., Kagan, H. M., “Metalloproteinse Activity Secreted by Fibrogenic Cells in the Processing of Prolysyl Oxidase”, J. Biol. Chem., 271(12): 7113-7119 (1996). |
Suzuki, N., Labosky, P. A., Furuta, Y., Hargett, L., Dunn, R., Fogo, A. B., Takahara, K., Peters, D. M., Greenspan, D. S., Hogan, B. L. M., “Failure of ventral body wall closure in mouse embryos lacking a procollagen C-proteinase encoded by Bmpl. mammalian gene related to Drosophila tolloid”, Development, 122: 3587-2595 (1996). |
Olsen, B. R., “Morphogenesis: Collagen it takes and bone it makes”, Current Biology, 6(6): 645-647 (1996). |
Gerling, B., Becker, M., Waldschmidt, J., Rehmann, M., Schuppan, D., “Elevated serum aminoterminal procollagen type-III-peptide parallels collagen accumulation in rats with secondary biliary fibrosis”, Journal of Hepatology, 25: 79-84 (1996). |
Kountouras, J., Billing, B. H., Scheuer, P. J., “Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat”, Br. J. Exp. Path., 65: 305-311 (1984). |
McLean, E. K., McLean, A. E. M., Sutton, P. M., “Instant Cirrhosis. An Improved Method for Producing Cirrhosis of the Liver in Rats by Simultaneous Administration of Carbon Tetrachloride and Phenobarbitone”, Br. J. Exp. Path., 50: 502-506 (1969). |
Johnson, S. J., Hines, J. E., Burt, A. D., “Phenotypic modulation of perisinusoidal cells following acute liver injury: a quantitative analysis”, Int. J. Exp. Path., 73: 765-772 (1992). |
Bickett, D. M., Green, M. D., Berman, J., Dezube, M., Howe, A. S., Brown, P. J., Roth, J. T., and McGeehan, G. M., A High Throughput Fluorogenic Substrate for Interstitial Collagenase (MMP-1) and Gelatinase (MMP-9), Analytical Biochemistry, 212: 58-64 (1993). |
Grant, G. A., Eisen, A. Z., Marmer, B. L., Roswit, W. T., and Goldberg, G. I., “The Activation of Human Skin Fibroblast Procollagenase”, The Journal of Biological Chemistry, 262(12): 5886-5889 (1987). |
Aimes, R. T., Quigley, J. P., “Matrix Metalloproteinase-2 is an Interstitial Collagenase”, J.Biol.Chem., 270(11): 5872-5876 (1995). |
Prockop, D. J., Sieron, A. L, Li, S.-W., “Procollagen N-Proteinase and Procollagen C-Proteinase. Two Unusual Metalloproteinases that are Essential for Procollagen Processing Probably have Important Roles in Development and Cell Signaling”, Matrix Biology, 16: 399-408 (1997/98). |
Wozney, J. M., Rosen, V., Celeste, A. J., Mitsock, L. M., Whitters, M. J., Kriz, R. W., Hewick, R. M., Wang, E. A., “Novel Regulators of Bone Formation: MolecularClones and Activities”, Science, 242: 1528-1534 (Dec. 1988). |
Matayoshi, E. D., Wang, G. T., Krafft, G. A., Erickson, J., “Novel Fluorogenic for Assaying Retroviral Proteases by Resonance Energy Transfer”, Science, 247: 954-958 (Feb. 1990). |
Lee, S.-T., Kessler, E., and Greenspan D. S., “Analysis of Site-directed Mutations in Human Pro-α2(1) Collagen which Block Cleavage by the C-proteinase”, J. Biol. Chem., 265(35): 21992-21996 (1990). |
Campagne, J.-M., Coste, J., Guillou, L., Heitz, A., and Jouin, P., “Solid Phase Synthesis of Phosphonic Peptides”, Tetrahedron Letters, 34(26): 4181-4184 (1993). |
Grams, F., Dive, V., Yiotakis, A., Yiallouros, I., Vassiliou, S., Zwilling, R., Bode, W., Stocker, W., “Structure of astacin with a transition-state analogue inhibitor”, Nature Structural Biology, 3(8): 671-675 (Aug. 1996). |
Stocker, W., Grams, F., Baumann, U., Reinemer, P., Gomis-Ruth, F.-X., McKay, D. B., Bode, W., “The metzincins-Topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenase) define a superfamily of zinc-peptidases”, Protein Science, 4: 823-840 (1995). |
Stocker, W., Gomis-Ruth, F.-X., Bode, W., Zwilling, R., “Implications of the three-dimensional structure of astacin for the structure and function of the astacin family of zinc-endopeptidases”, Eur. J. Biochem., 214: 215-231 (1993). |
Janitz, M., Heiser, V., Bottcher, U., Landt, O., Lauster, R., “Three alternatively spliced variants of the gene coding for the human bone morphogenetic protein-1”, J. Mol. Med., 76: 141-146 (1998). |
Li, S.-W., Sieron, A. I., Fertala, A., Hojima, Y., Arnold, W. V., Prockop, D. J., “The C-proteinase the processes procollagens to fibrillar collagens is identical to the protein previously identified as bone morphogenic protein-1”, Proc. Natl. Acad. Sci. USA, 93: 5127-5130 (1996). |
Burchardt, E. R., Schroder, W., Heke, M., Kohlmeyer, J., Neumann, R., Kroll, W., “Expression Cloning of C-Terminal Procollagen (III) Propeptide and its use in a Novel Serum Assay to Monitor Liver Fibronsis”, Hepatology, 26(4): 487A (1997). Abstract # 1435. |
Kauschke, S. G., Knorr, A., Olzen, M., Burchardt, E. R., “Expression of Collagne (III) as Determined by Quantitative PCR and its Correlation with Extracellular Collagen Deposition in the Rat CCL Model of Liver Fibrosis”, Hepatology, 538(A) (Oct. 1997) Abstract 1638. |
Amano, S., Takahara, K., Gerecke, D., Nishiyama, T., Lee, S., Greenspan, D. S., Burgeson, R. E., “Bone Morphogenetic Protein-1 is the Processing Enzyme for Laminin 5 in Human Keratinocytes”, Mol. Biol. Cell, 58A (1996) Abstract 338. |
Senoo, H., Wake, K., “Suppression of Experimental Hepatic Fibrosis by Administration of Vitamin A”, Lab. Invest., 52(2): 182-194 (1985). |